Zobrazeno 1 - 10 of 128 pro vyhledávání: '"Mark S. Walker"'
1
Akademický článek
A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection
Autor: Xiaohan Hu, Diana Chirovsky, Mark S. Walker, Yuexi Wang, Alpana Kaushiva, Jon Tepsick, Ayman Samkari
Publikováno v: BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Real-world data regarding patient characteristics, adjuvant treatment patterns, and long-term survival outcomes are needed to better understand unmet needs among patients with completely resected early-stage non-small cell lung ca
Externí odkaz: https://doaj.org/article/43a5e59b84124717bc48abca3c4b638a
Zobrazit plný text záznamu
2
Akademický článek
Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States
Autor: Himani Aggarwal, Rajeshwari S. Punekar, Li Li, Gebra Cuyun Carter, Mark S. Walker
Publikováno v: Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-14 (2020)
Abstract Background To compare quality of life of patients treated with cetuximab with or without radiation therapy (±RT) vs. cisplatin±RT for locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) in the real-world setting. M
Externí odkaz: https://doaj.org/article/4bbdccb926eb4645b3e424e7271cf9c2
Zobrazit plný text záznamu
3
Akademický článek
Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study
Autor: Mark S. Walker, William Wong, Arliene Ravelo, Paul J. E. Miller, Lee S. Schwartzberg
Publikováno v: Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-11 (2017)
Abstract Background Treatment options for advanced nonsquamous non-small cell lung cancer (NSCLC) in the first line include platinum-based doublet therapy with or without bevacizumab. This study examined efficacy outcomes and patient reported outcome
Externí odkaz: https://doaj.org/article/de2d5752a1e14c30b6d182dc09be2bf1
Zobrazit plný text záznamu
4
Akademický článek
A randomized controlled trial of directive and nondirective smoking cessation coaching through an employee quitline
Autor: Walton Sumner, Mark S. Walker, Gabrielle R. Highstein, Irene Fischer, Yan Yan, Amy McQueen, Edwin B. Fisher
Publikováno v: BMC Public Health, Vol 16, Iss 1, Pp 1-14 (2016)
Abstract Background Telephone quitlines can help employees quit smoking. Quitlines typically use directive coaching, but nondirective, flexible coaching is an alternative. Call-2-Quit used a worksite-sponsored quitline to compare directive and nondir
Externí odkaz: https://doaj.org/article/fee5528f5ac54b89875005cf27855025
Zobrazit plný text záznamu
7
Race Differences in Patient-Reported Symptoms during Chemotherapy among Women with Early-Stage Hormone Receptor–Positive Breast Cancer
Autor: Xin Hu, Cameron M. Kaplan, Michelle Y. Martin, Mark S. Walker, Edward Stepanski, Lee S. Schwartzberg, Gregory A. Vidal, Ilana Graetz
Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 32:167-174
Background: Symptom burden differences may contribute to racial disparities in breast cancer survival. We compared symptom changes from before to during chemotherapy among women with breast cancer. Methods: This observational study followed a cohort
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e59a5dca69ba5550935f2df1f3f4206a
https://doi.org/10.1158/1055-9965.epi-22-0692
Zobrazit plný text záznamu
8
Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer following complete resection
Autor: Howard West, Xiaohan Hu, Diana Chirovsky, Mark S Walker, Yuexi Wang, Alpana Kaushiva, Jon Tepsick, Ayman Samkari
Publikováno v: Future Oncology.
Aim: Real-world data on outcomes for early-stage non-small-cell lung cancer (NSCLC) are needed to better understand the benefits of new therapies. Methods: In this retrospective study using the ConcertAI Patient360™ database, overall survival and h
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96aa4a08a488e05cbb59f8b9c801af6c
https://doi.org/10.2217/fon-2023-0024
Zobrazit plný text záznamu
9
Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer
Autor: Xin Hu, Mark S. Walker, Edward Stepanski, Cameron M. Kaplan, Michelle Y. Martin, Gregory A. Vidal, Lee S. Schwartzberg, Ilana Graetz
Publikováno v: JAMA network open. 5(8)
Adjuvant endocrine therapy (AET) reduces breast cancer recurrence, but symptom burden is a key barrier to adherence. Black women have lower AET adherence and worse health outcomes than White women.To investigate the association between symptom burden
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc07be363990efb20c230892d56ac4d6
https://pubmed.ncbi.nlm.nih.gov/35947386
Zobrazit plný text záznamu
10
Treatment patterns and clinical outcomes of palbociclib-based therapy received in US community oncology practices
Autor: Junji Lin, Maxine D. Fisher, Lynn McRoy, Mark S. Walker, Cralen Davis, Nan Hu, Debanjali Mitra
Publikováno v: Future Oncology. 17:1001-1011
Background: Limited studies have evaluated palbociclib-based therapy use in patients with advanced/metastatic breast cancer in the real world. This retrospective study used medical records from US community oncology practices to address the gap. Mate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53bf272a45dd258dd25751687aa881a5
https://doi.org/10.2217/fon-2020-0744
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje